PlainPharmaWatch

CMS Open Payments · Program Year 2024

Kuros Biosciences AG

Kuros Biosciences AG reported $76,255.62 in payments to 6 physicians and teaching hospitals across 6 transactions.

See the rankings → How this is sourced
$76.3K
Total payments
6
Transactions
6
Recipients
−$7.4K
General Payments vs PY2023

Kuros Biosciences AG reported $76,255.62 in payments to 6 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #1251 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $12.7K per recipient across 1 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Kuros Biosciences AG pairs below-median payment volume with a moderately concentrated payment pattern.

#1251
of 1,925 companies
0.0%
of all US industry payments
0.2%
paid to its single top recipient
1
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Kuros Biosciences AG's CMS-reported General Payments decreased by $7.4K (−8.9%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: KUROS BIOSCIENCES AGPY2023: KUROS BIOSCIENCES AGPY2024: Kuros Biosciences AG. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$83.7KPY2024$76.3K
PY2023
$83,697.54
PY2024
$76,255.62

How Kuros Biosciences AG ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Kuros Biosciences AG's total vs. every reporting company

CMS Open Payments, Program Year 2024

$76,256 35th percentile higher than 35% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). This entry sits in this band. $78,003–$242,294: 295 reporting companies (15%). Above this entry. $242,294–$752,621: 270 reporting companies (14%). Above this entry. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Kuros Biosciences AG

Rank #1251 of 1,925 companies in CMS Open Payments for 2024 belongs to Kuros Biosciences AG, which reported $76,255.62 across 6 transactions to 6 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $12.7K per transaction and $12.7K per recipient.

6 transactions worth $76.3K make "Consulting Fee" the top general-payment category in the 1-category breakdown below, 100.0% of the reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Across 1 types of general payments, Kuros Biosciences AG's largest category was "Consulting Fee" at $76.3K - 100.0% of the company's reported total.

How Kuros Biosciences AG divides its payments

How the reported total splits across payment categories

1. Consulting Fee$76.3K
Payment Type Amount Transactions
Consulting Fee $76.3K 6

Recipient Concentration in General Payments

The five largest recipient relationships account for $65,662.49 (86.1%) of $76,255.62 in this company's General Payments records across 6 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Kuros Biosciences AG

The five named recipients with the highest reported General Payments from this company

Faheem Sandhu$14.4KAndrew Sama$14.3KKornelis Poelstra$12.5KRichard Allen$12.2KThomas Cha$12.2K
  1. 1

    Faheem Sandhu

    $14,352.84 across 1 reported transactions

  2. 2

    Andrew Sama

    $14,345.62 across 1 reported transactions

  3. 3

    Kornelis Poelstra

    $12,540.38 across 1 reported transactions

  4. 4

    Richard Allen

    $12,237.10 across 1 reported transactions

  5. 5

    Thomas Cha

    $12,186.55 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $12.7K. Average per recipient: $12.7K.

Total Amount

$76,255.62

Avg per Transaction

$12.7K

Avg per Recipient

$12.7K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Kuros Biosciences AG Share

0.0%

#1251 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Kuros Biosciences AG

Biocon Biologics Inc

$76.3K 733 recipients

Advanced Sterilization Products Services Inc.

$76.1K 6 recipients

Clinician's Choice Dental Products Inc.

$76.0K 46 recipients

Voom Medical Devices, Inc.

$76.9K 190 recipients

Medexus Pharma, Inc.

$75.6K 57 recipients

Pinnacle Biologics, Inc

$75.4K 342 recipients

Frequently Asked Questions

How much did Kuros Biosciences AG pay to physicians and hospitals in 2024? ▾
0.0% of all industry payments reported to CMS Open Payments for 2024 came from Kuros Biosciences AG, totaling $76,255.62 across 6 transactions to physicians and hospitals.
How many physicians received payments from Kuros Biosciences AG? ▾
Kuros Biosciences AG made payments to 6 physicians and teaching hospitals in 2024. The average payment per recipient was $12.7K.
What types of payments did Kuros Biosciences AG make? ▾
Kuros Biosciences AG made 1 different types of general payments (consulting, meals, travel, and similar categories). The largest general-payment category was "Consulting Fee" at $76.3K, representing 100.0% of the company's reported total.
How does Kuros Biosciences AG rank among pharmaceutical companies? ▾
Out of 1,925 companies in the CMS Open Payments database for 2024, Kuros Biosciences AG ranks #1251 by total payment amount.
What is the average payment size from Kuros Biosciences AG? ▾
The average transaction from Kuros Biosciences AG was $12.7K in 2024. The company made 6 total transactions to 6 recipients.
Where does the payment data for Kuros Biosciences AG come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Kuros Biosciences AG's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.